Guidance Document: QT/QTc Interval Prolongation: Guidance for Product Monograph Content [Health Canada, 2010] 来自 hc-sc.gc.ca 喜欢 0 阅读量: 25 作者: Government of Canada, Health Canada, Health Products and Food Branch, Therapeutic Products Directorate, Bureau of Policy Science and International...
If you want more information about BREYANZI: • Talk to your healthcare professional • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: https://www.canada.ca/en/health-canada/...
PRODUCT MONOGRAPH PrINCIVEK® Telaprevir Tablets 375 mg Antiviral Agent Manufactured by: Vertex Pharmaceuticals Incorporated Distributed by: Vertex Pharmaceuticals (Canada) Incorporated 275 Armand-Frappier Boulevard Laval, Quebec H7V 4A7 Submission Control No.: 161840 Date of Revision: December 17, ...
AMARYL: Product MonographHealth Canada
permissive language from Canada’s National Advisory Committee on Immunization with regard to heterologous mRNA vaccine schedules (first and second doses with different vaccines),6 and, during summer 2021, a gradual return to scheduling second doses in accordance with product monograph intervals followin...
Drug Information / Poison Control Centre: Subject: ACCUTANE™ ROCHE® (isotretinoin) – Revised Product MonographHoffmann-La Roche Ltd
Regarding the monograph, the acceptance value (AV) was calculated for each batch. The AV is required to not exceed a value of 15 (limit 1; L1). If the requirements for the first testing level (n = 10) are not met, 20 additional dosage forms need to be evaluated and the total AV ...